Literature DB >> 21172578

Diagnosis and treatment of major depressive disorder.

Laili Soleimani1, Kyle A B Lapidus, Dan V Iosifescu.   

Abstract

Major depressive disorder is a common illness, particularly in patients with medical and neurologic conditions. This article summarizes current data on the epidemiology, diagnosis, and treatment of major depression, with special emphasis on the diagnosis and treatment of depression in medical and neurologic patients. We reviewed the role of pharmacotherapies, psychotherapies, somatic treatments, and alternative remedies and we included practical advice for clinician regarding the timing and sequence of these treatments, the role of standardized depression scales, and the criteria for referrals to specialty consultants.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21172578     DOI: 10.1016/j.ncl.2010.10.010

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  9 in total

1.  Electroconvulsive therapy: a novel hypothesis for the involvement of purinergic signalling.

Authors:  Ahmed-Ramadan Sadek; Gillian E Knight; Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2011-06-22       Impact factor: 3.765

Review 2.  Circadian entrainment and its role in depression: a mechanistic review.

Authors:  G S Lall; L A Atkinson; S A Corlett; P J Broadbridge; D R Bonsall
Journal:  J Neural Transm (Vienna)       Date:  2012-07-14       Impact factor: 3.575

3.  Disruption of circadian rhythms: a crucial factor in the etiology of depression.

Authors:  Roberto Salgado-Delgado; Araceli Tapia Osorio; Nadia Saderi; Carolina Escobar
Journal:  Depress Res Treat       Date:  2011-08-08

4.  Nonlinear digital signal processing in mental health: characterization of major depression using instantaneous entropy measures of heartbeat dynamics.

Authors:  Gaetano Valenza; Ronald G Garcia; Luca Citi; Enzo P Scilingo; Carlos A Tomaz; Riccardo Barbieri
Journal:  Front Physiol       Date:  2015-03-13       Impact factor: 4.566

5.  The role of ketamine in treatment-resistant depression: a systematic review.

Authors:  Gianluca Serafini; Robert H Howland; Fabiana Rovedi; Paolo Girardi; Mario Amore
Journal:  Curr Neuropharmacol       Date:  2014-09       Impact factor: 7.363

6.  Association of circulating let-7b-5p with major depressive disorder: a nested case-control study.

Authors:  Sanne Roumans; Kristina Sundquist; Ashfaque A Memon; Anna Hedelius; Jan Sundquist; Xiao Wang
Journal:  BMC Psychiatry       Date:  2021-12-09       Impact factor: 3.630

7.  Neurobiological and pharmacological arguments for customization of cognitive behavioral psychotherapy in the treatment of major depressive disorder.

Authors:  Silvia Ristea; Ramona Adriana Schenker; Puiu Olivian Stovicek; Mihail Cristian Pîrlog; Dragoş Marinescu
Journal:  Rom J Morphol Embryol       Date:  2021 Jul-Sep       Impact factor: 0.833

8.  Morning light therapy for juvenile depression and severe mood dysregulation: study protocol for a randomized controlled trial.

Authors:  Sarah Bogen; Tanja Legenbauer; Thorsten Bogen; Stephanie Gest; Thomas Jensch; Silvia Schneider; Martin Holtmann
Journal:  Trials       Date:  2013-06-17       Impact factor: 2.279

9.  Effects of pharmaceutical medications on male fertility.

Authors:  Paul R Brezina; Fahd N Yunus; Yulian Zhao
Journal:  J Reprod Infertil       Date:  2012-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.